{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:45:22Z","timestamp":1788875122467,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gore.2025.101760","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T15:13:54Z","timestamp":1747408434000},"page":"101760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage"],"prefix":"10.1016","volume":"59","author":[{"given":"Rose","family":"Emlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Cosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Palisoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gore.2025.101760_b0005","doi-asserted-by":"crossref","first-page":"A2177","DOI":"10.1016\/j.chest.2022.08.1799","article-title":"Hemoptysis as primary manifestation in a woman with choriocarcinoma with pulmonary metastasis","volume":"162","author":"Ajja","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.gore.2025.101760_b0010","article-title":"EMA\/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis","volume":"23233709","author":"Alifrangis","year":"2013","journal-title":"J. Clin. Oncol.,"},{"issue":"3","key":"10.1016\/j.gore.2025.101760_b0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000533972","article-title":"Immunotherapy for gestational trophoblastic neoplasia: a new paradigm","volume":"89","author":"Baas","year":"2023","journal-title":"Gynecol. Obstet. Invest.,"},{"issue":"3","key":"10.1016\/j.gore.2025.101760_b0020","first-page":"175","article-title":"Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure","volume":"39","author":"Bakri","year":"1994","journal-title":"J. Reprod. Med."},{"issue":"1","key":"10.1016\/j.gore.2025.101760_b0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.18093\/0869-0189-2020-30-1-109-114","article-title":"Case of a placental site trophoblastic tumor that manifested a pulmonary hemorrhage","volume":"30","author":"Berdnikov","year":"2020","journal-title":"Russian Pulmonology"},{"issue":"10110","key":"10.1016\/j.gore.2025.101760_b0030","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.gore.2025.101760_b0035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/aogs.14404","article-title":"PD-L1 in gestational trophoblastic disease: an antibody evaluation","volume":"101","author":"Hoeijmakers","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand.,"},{"key":"10.1016\/j.gore.2025.101760_b0040","unstructured":"National Comprehensive Cancer Network. Gestational Trophoblastic Neoplasia (Version 2.2025). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gtn.pdf. Accessed January 10, 2025."},{"key":"10.1016\/j.gore.2025.101760_b0045","article-title":"Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979-2012 compared to 1962-1978","volume":"26047591","author":"Neubauer","year":"2015","journal-title":"Gynecol. Oncol.,"},{"key":"10.1016\/j.gore.2025.101760_b0050","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"30306586","author":"Ngan","year":"2018","journal-title":"Int. J. Gynaecol. Obstet.,"},{"key":"10.1016\/j.gore.2025.101760_b0055","doi-asserted-by":"crossref","unstructured":"Ren, Zhen, Yu, Li, Xie, Mengnv, Liang, Yiyi, Zhu, Fang, Huang, Rui, Zhang, Zhibang, Fu, Chun, 2018. Successful treatment of multisite hemorrhage by several methods in brain metastasis of choriocarcinoma: A case report. Medicine 97(21):p e10794, May. | DOI: 10.1097\/MD.0000000000010794.","DOI":"10.1097\/MD.0000000000010794"},{"key":"10.1016\/j.gore.2025.101760_b0060","article-title":"Gestational Trophoblastic Disease: Current Evaluation and Management","volume":"33416290","author":"Soper","year":"2021","journal-title":"Obstet. Gynecol.,"},{"issue":"6","key":"10.1016\/j.gore.2025.101760_b0065","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.gore.2025.101760_b0070","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/ijgc-00009577-200607000-00003","article-title":"Immunobiology of gestational trophoblastic diseases","volume":"16","author":"Wang","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"59","key":"10.1016\/j.gore.2025.101760_b0075","article-title":"Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study","volume":"27","author":"Wang","year":"2023","journal-title":"EClinicalMedicine."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:05:52Z","timestamp":1750215952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":15,"alternative-id":["S2352578925000852"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101760","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101760"}}